新宿・代々木こころのラボクリニック
平日21時まで。土日診療有り。新宿駅直結徒歩5分。代々木駅東口徒歩4分。

平成22年 American Psychiatric Association Research Colloquium for Junior Investigators

平成24年 American Society of Clinical Psychopharmacology Fellowship Award

平成25年 American Association for Geriatric Psychiatry Early Investigator Poster Award

平成25年 Society of Biological Psychiatry Travel Fellowship Award

平成25年 Asian Clinical Neuropsychophamarcology Travel Fellowship Award

平成26年 American Society of Clinical Psychopharmacology Annual Meeting New Investigator Award

平成26年 University of Toronto’s Best Accomplishment Fellow Award

平成26年 The International College of Geriatric Psychoneuropharmacology Young Investigator Award

平成27年 International Congress on Schizophrenia Research Young Investigator Travel Award

平成27年 American College of Neuropsychopharmacology travel award

平成27年 World Psychiatric Association International Congress Young Psychiatrist Award

平成28年 Schizophrenia International Research Society Conference’s travel award

平成28年 University of Toronto Department of Psychiatry’s Travel Award

平成28年 慶應義塾大学医学部三四会奨励賞

1.Nakajima S, Caravaggio F, Mamo D, Mulsant BH, Chung J, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T, Mar W, Wilson A, Houle S, Graff-Guerrero A. Dopamine D2/3 Receptor Availability in the Striatum of Antipsychotic-Free Patients with Late-Life Schizophrenia - a cross-sectional [11C]-raclopride PET study. Schizophrenia Research. 2015 May;164(1-3):263-7.

2.Nakajima S, Caravaggio F, Boileau I, Chung J, Plitman E, Gerretsen P, Wilson A, Houle S, Mamo D, Graff-Guerrero A. Lack of Decrease in Dopamine D3 receptor Availability - [11C]-(+)-PHNO and [11C]-Raclopride Positron Emision Tomography Study. Journal of Cerebral Blood Flow & Metabolism. 2015 Nov;35(11):1812-8.

3.Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada S, Wada M, Matsui M, Fujii S, Miyazaki T, Chakravarty MM, Uchida H, Remington G, Graff-Guerrero A, Mimura M, Nakajima S. Levels of Glutamatergic Neurometabolites in Patients with Severe Treatment-Resistant Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study. Neuropsychopharmacology. 2020 Mar;45(4):632-640.

4.Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M. Is Switching Antidepressants Following Early Nonresponse More Beneficial in Acute-Phase Treatment of Depression?: A Randomized Open-Label Trial. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1; 35(8):1983-1989.

5.Iwata Y, Nakajima S, Caravaggio F, Uchida H, Suzuki T, Plitman E, Mar W, Pollock B, Mulsant BH, Rajji TK, Mamo D, Graff-Guerrero A. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients with Schizophrenia. J Clin Psychiatry. 2016 Dec;77(12):e1557-e1563.

6.Nakajima S, Caravaggio F, Mamo D, Mulsant BH, Chung J, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T, Mar W, Wilson A, Houle S, Graff-Guerrero A. Dopamine D2/3 Receptor Availability in the Striatum of Antipsychotic-Free Patients with Late-Life Schizophrenia - a cross-sectional [11C]-raclopride PET study. Schizophrenia Research. 2015 May;164(1-3):263-7.

7.Nakajima S, Uchida H, Bies R, Caravaggio F, Suzuki T, Plitman E, Mar W, Pollock B, Mulsant B, Mamo D, Graff-Guerrero A. Predicting Dopamine D2 Receptor Occupancy Following Antipsychotic Dose Reduction. Schizophrenia Bulletin. 2016 Jan;42(1):212-9.

8.Graff-Guerrero A, Rajji T, Mulsant B, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock B, Mamo D. Maintenance Antipsychotic Dose Can Be Decreased in Late-life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study with [11C]-raclopride. JAMA Psychiatry. 2015 Sep;72(9):927-34.

9.Nakajima S (co-first), Iwata Y, Suzuki T, Keefe R, Plitman E, Chung J, Caravaggio F, Masaru M, Graff-Guerrero A, Uchida H. Effect of glutamatergic modulators on cognitive impairment in schizophrenia ? systematic review and meta-analysis. Molecular Psychiatry. 2015 Oct;20(10):1151-60.

10.Nakajima S (co-first), Iwata Y, Plitman E, Caravaggio F, Kim J, Shah P, Mar W, Chavez S, De Luca V, Mimura M, Remington G, Gerretsen P, Graff-Guerrero A. Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study. Biological Psychiatry. 2018 Sep 26.

»もっと見る